Circulating Tumor DNA Detection for Recurrence Monitoring of Stage I Non‐Small Cell Lung Cancer Treated With Microwave Ablation by Lin Cheng, Sheng Xu, Yu‐feng Wang, Sheng‐wei Li, Bin Li, Xiao‐Guang Li

“…ABSTRACT Purpose As microwave ablation continues to be used in patients with inoperable stage I non‐small cell lung cancer (NSCLC), it is particularly important to monitor efficacy. …”
Get full text

Prevalence and influencing factors of the dyadic psychological stress among patients with lung cancer and their family caregivers: a cross-sectional study by Juan Li, Chan Li, Jie Zou, Fang-Qun Cheng, Li Peng, Li-Hong Deng, Pei-Pei Wu, Sai-Yu Gao, Zhi-Yao Xiong, Ying Zuo, Yan Luo, Xiao-Hua Rao, Bo Yuan, Ou-Ying Chen, Jing-Ping Zhang

Subjects: “…Lung cancer patients…”
Get full text

Radiomics for differentiating adenocarcinoma and squamous cell carcinoma in non-small cell lung cancer beyond nodule morphology in chest CT by Minmini Selvam, Abjasree Sadanandan, Anupama Chandrasekharan, Sidharth Ramesh, Arunan Murali, Ganapathy Krishnamurthi

“…Abstract Distinguishing between primary adenocarcinoma (AC) and squamous cell carcinoma (SCC) within non-small cell lung cancer (NSCLC) tumours holds significant management implications. …”
Get full text

Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis by Preston Ngo, Wendy A. Cooper, Stephen Wade, Kwun M. Fong, Karen Canfell, Deme Karikios, Marianne Weber

Subjects: Get full text

A Case of Non-Small Cell Lung Cancer with Mutually Exclusive <i>EGFR</i> and <i>KRAS</i> Mutations by Abhimanyu Tushir, Israh Akhtar, Anjali Seth

Get full text

Associations of Concordant and Shared Lung Cancer Screening Decision Making with Decisional Conflict: A Multi-Institution Cross-Sectional Analysis by Donald R. Sullivan, Sara E. Golden, Liana Schweiger, Anne C. Melzer, Santanu Datta, James M. Davis, Renda Soylemez Wiener, Christopher G. Slatore

“…Many organizations recommend structured communication processes, including formal shared decision making (SDM), for patients undergoing lung cancer screening (LCS) using low-dose computed tomography (LDCT). …”
Get full text

Comparative study of degree, neighborhood and reverse degree based indices for drugs used in lung cancer treatment through QSPR analysis by Micheal Arockiaraj, J. J. Jeni Godlin, S. Radha, Tariq Aziz, Mitub Al-harbi

“…This study focuses on the selection of drugs used to treat lung cancer, including dacomitinib, selpercatinib, tepotinib, trametinib, sotorasib, etoposide, alectinib, paclitaxel, dabrafenib, entrectinib, crizotinib, ceritinib, lorlatinib, afatinib, pralsetinib, brigatinib, erlotinib, adagrasib, gefitinib, vinorelbine, gemcitabine, docetaxel, and pemetrexed. …”
Get full text

Radiotherapy(R) Integration(I) Strategy for Small(S)-Cell Lung Cancer in Extensive(E) Stage (RISE) with up to 10 metastases- a study protocol of a randomized phase II trial by Łukasz Kuncman, Jacek Fijuth, Damian Tworek, Ewa Sierko, Paweł Cisek, Michał Masłowski, Maja Lisik-Habib, Magdalena Orzechowska, Katarzyna Galwas-Kliber, Adam Antczak, Izabela Chmielewska, Barbara Ziółkowska, Marta Kurczewska-Michalak, Wojciech Kuźnicki, Nina Jędrzejczak, Kinga Ranoszek, Mateusz Bilski

Subjects: “…Lung cancer…”
Get full text

Molecular characterization of EBV-associated primary pulmonary lymphoepithelial carcinoma by multiomics analysis by Meiling Yang, Guixian Zheng, Fukun Chen, Haijuan Tang, Yaoyao Liu, Xuan Gao, Yu Huang, Zili Lv, Benhua Li, Maolin Yang, Qing Bu, Lixia Zhu, Pengli Yu, Zengyu Huo, Xinyan Wei, Xiaoli Chen, Yanbing Huang, Zhiyi He, Xuefeng Xia, Jing Bai

Subjects: “…Lung cancer…”
Get full text

Ultrasound guided thoracic dorsal root ganglia pulsed radiofrequency verified by fluroscopy for patients with lung cancer and metastatic thoracic cage pain: a randomized controlled study by Dina Kamel Abdel Maksoud, Sahar Ahmed El Karadway, Nagwa Ahmed Ibrahim, Dina Nabil Abbbas

Subjects: Get full text

Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan by Jerry Shu-Hung Kuo, Cheng-Yu Chang, Shih-Chieh Chang, Yu-Feng Wei, Chung-Yu Chen

Subjects: Get full text

All that glitters on chest radiology is not tuberculosis by Madhav Mahawar, Shreeshail Anjutagi, Keertivardhan D. Kulkarni, B. Likhitha

Subjects: Get full text

Iatrogenic intramural esophageal hematoma during EUS-B-FNA procedure by João Oliveira Rodrigues, Paulo Matos, Luís Vaz Rodrigues, Michele de Santis, Lourdes Barradas

Subjects: Get full text

Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro by Liu Rui, Jiang Cuihong, Zhao Zhizheng, Lv Yutong, Wang Gaoxing

Subjects: “…small-cell lung cancer…”
Get full text

Economic Evaluation of a Novel Lung Cancer Diagnostic in a Population of Patients with a Positive Low-Dose Computed Tomography Result by Michael J. Morris, Sheila A. Habib, Maggie L. Do Valle, John E. Schneider

“…**Background:** Early detection of lung cancer is crucial for improving patient outcomes. …”
Get full text

Progress of nursing interventions on malnutrition among patients with lung cancer (肺癌患者营养不良的护理干预研究进展) by ZHOU Yan (周艳), YUAN Ting (袁婷), FENG Juan (冯娟), YANG Zhen (杨珍)

Subjects: “…lung cancer…”
Get full text

Surgery versus concurrent chemoradiotherapy for stage III non-small cell lung cancer: a retrospective study with propensity score matching by Takao Shigenobu, Yuri Taniguchi, Takahiro Suzuki, Yuya Tabuchi, Mizuki Sato, Kazumasa Odagiri, Yukiko Nakamura, Tsuneo Shimokawa, Hiroaki Okamoto, Akira Yoshizu

“…Abstract Background No study has directly compared the outcomes of surgery and concurrent chemoradiotherapy (cCRT) in patients with stage III non-small cell lung cancer (NSCLC) to date. This study aimed to compare the treatment efficacy of complete resection and definitive cCRT. …”
Get full text

Syzygium malaccense leaf extract-mediated silver nanoparticles: synthesis, characterization, and biomedical evaluation in Caenorhabditis elegans and lung cancer cell line by Santosh Mallikarjun Bhavi, Bothe Thokchom, Sapam Riches Singh, Sukesh Kumar Bajire, Rajesh P. Shastry, B. S. Srinath, Shivanand S. Bhat, Kotresha Dupadahalli, Chandramohan Govindasamy, Swati Ravi Chalekar, B. P. Harini, Ramesh Babu Yarajarla

Get full text

Altered Ca2+-Homeostasis of Cisplatin-Treated and Low Level Resistant Non-Small-Cell and Small-Cell Lung Cancer Cells by Kathrin Schrödl, Hamza Oelmez, Martin Edelmann, Rudolf Maria Huber, Albrecht Bergner

“…Background: Chemotherapy often leads to encouraging responses in lung cancer. But, in the course of the treatment, resistance to chemotherapy ultimately limits the life expectancy of the patient. …”
Get full text

The Association Between Body Composition, Overall Survival, Treatment Decisions, and Patient‐Reported Outcomes in Metastatic Non‐Small‐Cell Lung Cancer by Adriana M. Coletta, Hyejung Lee, Sonam Puri, Sinead Culleton, Matthew F. Covington, Jeffrey T. Yap, Kelsey E. Maslana, Benjamin Haaland, Wallace Akerley

“…ABSTRACT Introduction The purpose of this study was to evaluate the association between body composition, overall survival, odds of receiving treatment, and patient‐reported outcomes (PROs) in individuals living with metastatic non‐small‐cell lung cancer (mNSCLC). Methods This retrospective analysis was conducted in newly diagnosed patients with mNSCLC who had computed‐tomography (CT) scans and completed PRO questionnaires close to metastatic diagnosis date. …”
Get full text